Demethoxycurcumin (DMC), a bioactive curcuminoid, selectively induces cytotoxicity in NSCLC cells by downregulating ERCC1 via the PI3K/Akt/Snail pathway and suppressing thymidine phosphorylase (TP) expression [98]. Here, ERCC1 is linked to non-small cell lung carcinoma.